New SURGIFLO™ is now faster, simpler and more consistent to prepare

New SURGIFLO™ is now faster, simpler and more consistent to prepare

Johnson & Johnson, a global leader in surgical technologies and solutions, has launched new SURGIFLO™ Hemostatic Matrix Kit with Thrombin, which delivers the same trusted efficacy1* as the current SURGIFLO™, but now with an unbeatable preparation time.1†

SURGIFLO™ is a flowable, gelatin-based hemostatic matrix used in surgical procedures to stop bleeding. It is particularly effective in difficult-to-access bleeding2-8, where surgeons are faced with challenges including limited visibility or an uneven bleeding surface.

Like all flowable hemostats, SURGIFLO™ must be mixed and prepared in the operating room (OR) before use. Time is of the essence, and any preparation delays can be associated with increased stress. SURGIFLO™ now delivers the same trusted efficacy with faster, simpler and more consistent preparation1*, making it 36% faster than the current SURGIFLO™1* and more than 2.5 times faster than a leading competitor.

“We are delighted to support surgeons and patients across the EMEA region with our new SURGIFLO™ Hemostatic Matrix Kit with Thrombin,” said Francois Gaudemet, President, Surgery EMEA. “When there’s an urgent bleed in the operating room, surgeons need a hemostat immediately, and any delay can be stressful. New SURGIFLO™ is a fast and effective way to control blood loss.”

New SURGIFLO also uses less components and has a lower environmental impact.   

*Based participants feedback to SURGIFLO™ MS0016 Non-Clinical Product Claims.
Compared to SURGIFLO™ MS0012 Haemostatic Matrix Kit with Thrombin and Floseal Haemostatic Matrix 5 ml

†Compared to SURGIFLO™ Hemostatic Matrix Kit with Thrombin (MS0012) and Floseal
Haemostatic Matrix 5 ml

‡Compared to SURGIFLO™(MS0012)

±Compared to Floseal Haemostatic Matrix 5 ml

§Compared to SURGIFLO™ Hemostatic Matrix Kit with Thrombin (MS0012) and Floseal Haemostatic Matrix 5 ml

References

  1. Ferrosan Medical Devices.Time Motion Study Report MS0016.9/02/2026
  2. Surgiflo TM Haemostatic Matrix Instructions for use 2022; 4548686 ;MS0010
  3. Surgiflo TM Haemostatic Matrix With Thrombin Instructions for use 2022; 4548699; MS0012
  4. Gazzeri R, Galarza M, Alex AThe Saftey and Biocompatibility Of
  5. Gelatin Hemostatic Matrix (Floseal and Surgiflo) In Neurosurgical Procedures; 2012; SFL-183-12
  6. G.Buiret, M.Pavic, J.C.Pignat and F.Pasquet Gelatin Thrombin Matrix:
  7. A New and Simple Way to Manage Recurrent Expistaxis in Hematology Units 2013; 10.1155; 851270
  8. E.Cantone; American Journal of Emergency Medicine 2014; 0735-6757

©Johnson and Johnson and its affiliates 2026. M_EM_SRG_BIOS_417334

The third-party trademarks used herein are the trademarks of their respective owners.

Important Information: Please refer to the latest Instructions for Use and/or Package Insert provided by the manufacturer of the device for the details such as indications, contraindications, side effects, warnings, and precautions.